Total Aset Bersih: Acasti Pharma Inc. (ACST)

Acasti Pharma (ACST) focuses on therapies for rare heart and brain pathologies. This price chart highlights the non-cyclical nature of the business, whose stability relies on internal liquidity, with the indicator standing at 0.05. Acasti Pharma is developing a pipeline of treatments for orphan diseases and is completing critical tests. Particular emphasis is placed on transmucosal delivery methods, which allow medications to bypass digestion and reach their target more rapidly.

This metric serves as a critical filter during asset stress testing, measuring the actual net asset value to assess the business's intrinsic resilience. Analyzing the book capitalization level of Acasti Pharma (ACST) helps identify the risk of capital freezing, which is particularly relevant for Acasti Pharma (ACST) due to the lack of revenue and the linear cash burn associated with clinical trials of its molecules.